Prevalence of hepatic complications according to no or mild, moderate, and severe PLD.

Presence and severity of non- in a large prospective p

Matthew J. Armstrong
Diarmaid D. Houl
Robert Cramb
Simon Olliff
Richard J. Lilford
See Editorial Pa

January 2011

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is tics.gov.uk). In parallel with t...

Prevalence of overweight, obesity, central obesity, and raised ALT levels, overall and by MRS or ultrasound categories of hepatic steatosis.

Emanuella De Lucia Rolfe (3571172)
Soren Brage (198651)
Alison Sleigh (504084)
Francis Finucane (3728638)
Simon J. Griffin (428568)
Nick J. Wareham (433561)
Ken K. Ong (188600)
Nita G. Forouhi (130774)

November 2018

Prevalence of overweight, obesity, central obesity, and raised ALT levels, overall and by MRS or ult...

Comparison of short-term mortality rates based on liver decompensation severity.

Tongluk Teerasarntipan (9223413)
Kessarin Thanapirom (792131)
Sakkarin Chirapongsathorn (14159965)
Tanita Suttichaimongkol (14159968)
Naichaya Chamroonkul (12281795)
Chalermrat Bunchorntavakul (3838855)
Sith Siramolpiwat (387333)
Siwaporn Chainuvati (6941075)
Abhasnee Sobhonslidsuk (840642)
Apinya Leerapun (3838852)
Teerha Piratvisuth (279131)
Wattana Sukeepaisarnjaroen (279136)
Tawesak Tanwandee (279135)
Sombat Treeprasertsuk (792133)

November 2022

Comparison of short-term mortality rates based on liver decompensation severity.</p

The prevalence of metabolic syndrome and fatty liver disease in different HL groups.

Yuan-Lung Cheng (449366)
Jiah-Hwang Shu (5029532)
Hsiu-Chuan Hsu (5029538)
Ying Liang (13730)
Ruey-Hsing Chou (5029544)
Pai-Feng Hsu (5029535)
Yuan-Jen Wang (449367)
Yaw-Zon Ding (5029541)
Teh-Ling Liou (5029529)
Ying-Wen Wang (404816)
Shao-Sung Huang (312696)
Chung-Chi Lin (800995)
Tse-Min Lu (442994)
Hsin-Bang Leu (174682)
Shing-Jong Lin (174700)
Wan-Leong Chan (303047)

March 2018

The prevalence of metabolic syndrome and fatty liver disease in different HL groups.</p

Prevalence of liver damage detected by TE and LB in patients at risk for NASH stratified by BMI.

Maricruz Sepulveda-Villegas (6175610)
Sonia Roman (844085)
Ingrid Rivera-Iñiguez (6175613)
Claudia Ojeda-Granados (6175616)
Karina Gonzalez-Aldaco (844083)
Luis Alberto Torres-Reyes (6175619)
Alexis Jose-Abrego (6175622)
Arturo Panduro (844092)

January 2019

Prevalence of liver damage detected by TE and LB in patients at risk for NASH stratified by BMI.</p

Prevalence of abdominal symptoms and hepatic complications.

Hyunsuk Kim (762545)
Hayne Cho Park (439015)
Hyunjin Ryu (834646)
Kiwon Kim (834647)
Hyo Sang Kim (834648)
Kook-Hwan Oh (295901)
Su Jong Yu (313985)
Jin Wook Chung (530628)
Jeong Yeon Cho (753403)
Seung Hyup Kim (834649)
Hae Il Cheong (191547)
Kyubeck Lee (834650)
Jong Hoon Park (513718)
York Pei (834651)
Young-Hwan Hwang (834652)
Curie Ahn (304029)

December 2015

(A) The prevalence of hepatic complications of all subjects. (B) The prevalence of abdominal symp...

Observed and expected prevalences for hypertension and lipid metabolism disorders.

Ingmar Schäfer (307515)

February 2013

Observed and expected prevalences for hypertension and lipid metabolism disorders.</p

Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis.

Siddiqui, Mohammad Shadab
Carbone, Salvatore
Vincent, Robert
Patel, Samarth S, MD
Driscoll, Carolyn
Celi, Francesco S
Billingsley, Hayley
Rotelli, Brando
John, Binu
Potere, Nicola
Viscusi, Michele
Adiletta, Veronica
Sanyal, Arun J
Luketic, Velimir A
Reichman, Trevor
Bhati, Chandra S

September 2019

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting nearly ...

Description of liver disease etiologies, comorbidities and Child-Pugh-Turcotte classification in numbers and percentage in the analyzed population (N = 166).

Benedict Kinny-Köster (528438)
Michael Bartels (528439)
Susen Becker (799699)
Markus Scholz (157675)
Joachim Thiery (66414)
Uta Ceglarek (144203)
Thorsten Kaiser (427544)

July 2016

Description of liver disease etiologies, comorbidities and Child-Pugh-Turcotte classification in ...

Cumulative incidence of non-alcoholic fatty liver disease by quartile of serum direct bilirubin concentration.

Yoosoo Chang (164509)
Seungho Ryu (164515)
Yiyi Zhang (164519)
Hee Jung Son (164523)
Jang-Young Kim (164528)
Juhee Cho (164532)
Eliseo Guallar (27363)

May 2012

Cumulative incidence of non-alcoholic fatty liver disease by quartile of serum direct bilirubin c...

Specific Hepatic Complications and Mortality (n = 87)*.

Jack X. Q. Pang (587673)
Scott Zimmer (587674)
Sophia Niu (587675)
Pam Crotty (587676)
Jenna Tracey (587677)
Faruq Pradhan (587678)
Abdel Aziz M. Shaheen (101865)
Carla S. Coffin (587679)
Steven J. Heitman (359506)
Gilaad G. Kaplan (124401)
Mark G. Swain (587680)
Robert P. Myers (101862)

April 2014

*Individual patients could have multiple complications; hence the total (n = 124) exceeds 87 pati...

Prevalence of Liver Disease and Utilization of a Hepatology Consultation Service at an Urban Tertiary Care Hospital

Wong, Stephen G
Pollock, Richard
Minuk, Gerald Y

December 2015

Purpose: The prevalence of liver disease and frequency of consultations to a Hepatology Consultation...

Patient hepatic pathologies.

Chera L. Maarouf (164216)
Jessica E. Walker (5729015)
Lucia I. Sue (622614)
Brittany N. Dugger (5729018)
Thomas G. Beach (129083)
Geidy E. Serrano (2833265)

September 2018

Miscellaneous Benning Hepatic Pathologies present in all the cases used in this study. (DOCX)</p

Incidence rates of clinical outcomes according to fibrosis and risk category defined by non-invasive tools, liver histology and HVPG.

Giada Sebastiani (204344)
Rasha Alshaalan (756320)
Philip Wong (73144)
Maria Rubino (756321)
Ayat Salman (661317)
Peter Metrakos (71919)
Marc Deschenes (756322)
Peter Ghali (756323)

June 2015

Legend: PY, persons year; CI, confidence interval; HVPG, hepatic venous pressure gradient; APRI, ...

The prevalence of liver calcification as well as calcified metastatic lesions MEN1 and MEN2 groups.

Nassim Fard (6411125)
Heinz-Peter Schlemmer (392839)
Friedhelm Raue (674798)
Björn Jobke (346187)

February 2019

The prevalence of liver calcification as well as calcified metastatic lesions MEN1 and MEN2 groups.<...

Presence and severity of non- in a large prospective p

Matthew J. Armstrong
Diarmaid D. Houl
Robert Cramb
Simon Olliff
Richard J. Lilford
See Editorial Pa

January 2011

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is tics.gov.uk). In parallel with t...

Prevalence of overweight, obesity, central obesity, and raised ALT levels, overall and by MRS or ultrasound categories of hepatic steatosis.

Emanuella De Lucia Rolfe (3571172)
Soren Brage (198651)
Alison Sleigh (504084)
Francis Finucane (3728638)
Simon J. Griffin (428568)
Nick J. Wareham (433561)
Ken K. Ong (188600)
Nita G. Forouhi (130774)

November 2018

Prevalence of overweight, obesity, central obesity, and raised ALT levels, overall and by MRS or ult...

Comparison of short-term mortality rates based on liver decompensation severity.

Tongluk Teerasarntipan (9223413)
Kessarin Thanapirom (792131)
Sakkarin Chirapongsathorn (14159965)
Tanita Suttichaimongkol (14159968)
Naichaya Chamroonkul (12281795)
Chalermrat Bunchorntavakul (3838855)
Sith Siramolpiwat (387333)
Siwaporn Chainuvati (6941075)
Abhasnee Sobhonslidsuk (840642)
Apinya Leerapun (3838852)
Teerha Piratvisuth (279131)
Wattana Sukeepaisarnjaroen (279136)
Tawesak Tanwandee (279135)
Sombat Treeprasertsuk (792133)

November 2022

Comparison of short-term mortality rates based on liver decompensation severity.</p

The prevalence of metabolic syndrome and fatty liver disease in different HL groups.

Yuan-Lung Cheng (449366)
Jiah-Hwang Shu (5029532)
Hsiu-Chuan Hsu (5029538)
Ying Liang (13730)
Ruey-Hsing Chou (5029544)
Pai-Feng Hsu (5029535)
Yuan-Jen Wang (449367)
Yaw-Zon Ding (5029541)
Teh-Ling Liou (5029529)
Ying-Wen Wang (404816)
Shao-Sung Huang (312696)
Chung-Chi Lin (800995)
Tse-Min Lu (442994)
Hsin-Bang Leu (174682)
Shing-Jong Lin (174700)
Wan-Leong Chan (303047)

March 2018

The prevalence of metabolic syndrome and fatty liver disease in different HL groups.</p

Prevalence of liver damage detected by TE and LB in patients at risk for NASH stratified by BMI.

Maricruz Sepulveda-Villegas (6175610)
Sonia Roman (844085)
Ingrid Rivera-Iñiguez (6175613)
Claudia Ojeda-Granados (6175616)
Karina Gonzalez-Aldaco (844083)
Luis Alberto Torres-Reyes (6175619)
Alexis Jose-Abrego (6175622)
Arturo Panduro (844092)

January 2019

Prevalence of liver damage detected by TE and LB in patients at risk for NASH stratified by BMI.</p

Prevalence of abdominal symptoms and hepatic complications.

Hyunsuk Kim (762545)
Hayne Cho Park (439015)
Hyunjin Ryu (834646)
Kiwon Kim (834647)
Hyo Sang Kim (834648)
Kook-Hwan Oh (295901)
Su Jong Yu (313985)
Jin Wook Chung (530628)
Jeong Yeon Cho (753403)
Seung Hyup Kim (834649)
Hae Il Cheong (191547)
Kyubeck Lee (834650)
Jong Hoon Park (513718)
York Pei (834651)
Young-Hwan Hwang (834652)
Curie Ahn (304029)

December 2015

(A) The prevalence of hepatic complications of all subjects. (B) The prevalence of abdominal symp...

Observed and expected prevalences for hypertension and lipid metabolism disorders.

Ingmar Schäfer (307515)

February 2013

Observed and expected prevalences for hypertension and lipid metabolism disorders.</p

Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis.

Siddiqui, Mohammad Shadab
Carbone, Salvatore
Vincent, Robert
Patel, Samarth S, MD
Driscoll, Carolyn
Celi, Francesco S
Billingsley, Hayley
Rotelli, Brando
John, Binu
Potere, Nicola
Viscusi, Michele
Adiletta, Veronica
Sanyal, Arun J
Luketic, Velimir A
Reichman, Trevor
Bhati, Chandra S

September 2019

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting nearly ...

Description of liver disease etiologies, comorbidities and Child-Pugh-Turcotte classification in numbers and percentage in the analyzed population (N = 166).

Benedict Kinny-Köster (528438)
Michael Bartels (528439)
Susen Becker (799699)
Markus Scholz (157675)
Joachim Thiery (66414)
Uta Ceglarek (144203)
Thorsten Kaiser (427544)

July 2016

Description of liver disease etiologies, comorbidities and Child-Pugh-Turcotte classification in ...

Cumulative incidence of non-alcoholic fatty liver disease by quartile of serum direct bilirubin concentration.

Yoosoo Chang (164509)
Seungho Ryu (164515)
Yiyi Zhang (164519)
Hee Jung Son (164523)
Jang-Young Kim (164528)
Juhee Cho (164532)
Eliseo Guallar (27363)

May 2012

Cumulative incidence of non-alcoholic fatty liver disease by quartile of serum direct bilirubin c...

Specific Hepatic Complications and Mortality (n = 87)*.

Jack X. Q. Pang (587673)
Scott Zimmer (587674)
Sophia Niu (587675)
Pam Crotty (587676)
Jenna Tracey (587677)
Faruq Pradhan (587678)
Abdel Aziz M. Shaheen (101865)
Carla S. Coffin (587679)
Steven J. Heitman (359506)
Gilaad G. Kaplan (124401)
Mark G. Swain (587680)
Robert P. Myers (101862)

April 2014

*Individual patients could have multiple complications; hence the total (n = 124) exceeds 87 pati...

Prevalence of Liver Disease and Utilization of a Hepatology Consultation Service at an Urban Tertiary Care Hospital

Wong, Stephen G
Pollock, Richard
Minuk, Gerald Y

December 2015

Purpose: The prevalence of liver disease and frequency of consultations to a Hepatology Consultation...

Patient hepatic pathologies.

Chera L. Maarouf (164216)
Jessica E. Walker (5729015)
Lucia I. Sue (622614)
Brittany N. Dugger (5729018)
Thomas G. Beach (129083)
Geidy E. Serrano (2833265)

September 2018

Miscellaneous Benning Hepatic Pathologies present in all the cases used in this study. (DOCX)</p

Incidence rates of clinical outcomes according to fibrosis and risk category defined by non-invasive tools, liver histology and HVPG.

Giada Sebastiani (204344)
Rasha Alshaalan (756320)
Philip Wong (73144)
Maria Rubino (756321)
Ayat Salman (661317)
Peter Metrakos (71919)
Marc Deschenes (756322)
Peter Ghali (756323)

June 2015

Legend: PY, persons year; CI, confidence interval; HVPG, hepatic venous pressure gradient; APRI, ...

The prevalence of liver calcification as well as calcified metastatic lesions MEN1 and MEN2 groups.

Nassim Fard (6411125)
Heinz-Peter Schlemmer (392839)
Friedhelm Raue (674798)
Björn Jobke (346187)

February 2019

The prevalence of liver calcification as well as calcified metastatic lesions MEN1 and MEN2 groups.<...

Presence and severity of non- in a large prospective p

Matthew J. Armstrong
Diarmaid D. Houl
Robert Cramb
Simon Olliff
Richard J. Lilford
See Editorial Pa

January 2011

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is tics.gov.uk). In parallel with t...

Prevalence of overweight, obesity, central obesity, and raised ALT levels, overall and by MRS or ultrasound categories of hepatic steatosis.

Emanuella De Lucia Rolfe (3571172)
Soren Brage (198651)
Alison Sleigh (504084)
Francis Finucane (3728638)
Simon J. Griffin (428568)
Nick J. Wareham (433561)
Ken K. Ong (188600)
Nita G. Forouhi (130774)

November 2018

Prevalence of overweight, obesity, central obesity, and raised ALT levels, overall and by MRS or ult...

Comparison of short-term mortality rates based on liver decompensation severity.

Tongluk Teerasarntipan (9223413)
Kessarin Thanapirom (792131)
Sakkarin Chirapongsathorn (14159965)
Tanita Suttichaimongkol (14159968)
Naichaya Chamroonkul (12281795)
Chalermrat Bunchorntavakul (3838855)
Sith Siramolpiwat (387333)
Siwaporn Chainuvati (6941075)
Abhasnee Sobhonslidsuk (840642)
Apinya Leerapun (3838852)
Teerha Piratvisuth (279131)
Wattana Sukeepaisarnjaroen (279136)
Tawesak Tanwandee (279135)
Sombat Treeprasertsuk (792133)

November 2022

Comparison of short-term mortality rates based on liver decompensation severity.</p

Prevalence of hepatic complications according to no or mild, moderate, and severe PLD.

Abstract

Extracted data

Prevalence of hepatic complications according to no or mild, moderate, and severe PLD.

Abstract

Extracted data

Related items

Related items